No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs2167289 |
chr7:127857891-127857892 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs181442691 |
chr7:127857902-127857903 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs534147414 |
chr7:127857903-127857904 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs535271211 |
chr7:127857969-127857970 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs570981196 |
chr7:127857981-127857982 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs11764840 |
chr7:127858048-127858049 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
7 |
rs370073802 |
chr7:127858051-127858052 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs7785591 |
chr7:127858084-127858085 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
9 |
rs539324405 |
chr7:127858095-127858096 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs558009882 |
chr7:127858134-127858135 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs538378962 |
chr7:127858147-127858148 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs375935847 |
chr7:127858150-127858151 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs78332539 |
chr7:127858168-127858169 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs150415398 |
chr7:127858188-127858189 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs138210072 |
chr7:127858192-127858193 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs551673424 |
chr7:127858229-127858230 |
Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs185777777 |
chr7:127858283-127858284 |
Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs142889168 |
chr7:127858291-127858292 |
Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs540056340 |
chr7:127858315-127858316 |
Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs561781727 |
chr7:127858332-127858333 |
Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs540224245 |
chr7:127858349-127858350 |
Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs561812893 |
chr7:127858351-127858352 |
Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs528971162 |
chr7:127858403-127858404 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs560127289 |
chr7:127858413-127858414 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs550694632 |
chr7:127858425-127858426 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs75374373 |
chr7:127858444-127858445 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs145993091 |
chr7:127858452-127858453 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs138696805 |
chr7:127858455-127858456 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs79567353 |
chr7:127858477-127858478 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs534088749 |
chr7:127858493-127858494 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs528679831 |
chr7:127858505-127858506 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs375001198 |
chr7:127858510-127858511 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs549304463 |
chr7:127858515-127858516 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs567895924 |
chr7:127858522-127858523 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs537930849 |
chr7:127858553-127858554 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs74729328 |
chr7:127858613-127858614 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs190101991 |
chr7:127858656-127858657 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs562672315 |
chr7:127858720-127858721 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs531817985 |
chr7:127858721-127858722 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs114827227 |
chr7:127858723-127858724 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs141817164 |
chr7:127858765-127858766 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs115403248 |
chr7:127858820-127858821 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs59464399 |
chr7:127858911-127858912 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
44 |
rs116390122 |
chr7:127858923-127858924 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs144621374 |
chr7:127858933-127858934 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs115747503 |
chr7:127858958-127858959 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs562257192 |
chr7:127858965-127858966 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs180986540 |
chr7:127858969-127858970 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs544616380 |
chr7:127859017-127859018 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs185858011 |
chr7:127859024-127859025 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|